Akt-FOXO3a signaling affects human endothelial progenitor cell differentiation

Hypertension Research

Volumn 31, Issue 1, 2008, Pages 153-159

  Mogi, Masaki ^a,b   Walsh, Kenneth ^b   Iwai, Masaru ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Akt; Differentiation; Endothelial progenitor cells; FOXO3a; Mononuclear cells

Indexed keywords

ADENOVIRUS VECTOR; FIBRONECTIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR FKHRL1;

ARTICLE; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENDOTHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STEM CELL; UPREGULATION; WESTERN BLOTTING;

ADENOVIRIDAE; BLOTTING, WESTERN; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; MONOCYTES; ONCOGENE PROTEIN V-AKT; SIGNAL TRANSDUCTION; STEM CELLS; UP-REGULATION;

EID: 40149087504     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.153     Document Type: Article

References (28)

1. Datta SR, Brunet A, Greenberg ME: Cellular survival: a play in three Akts. Genes Dev 1999; 13: 2905-2927.
2. Mogi M, Yang J, Lambert JF, et al: Akt signaling regulates side population cell phenotype via Bcrp1 translocation. J Biol Chem 2003; 278: 39068-39075.
3. Fujio Y, Guo K, Mano, T, Mitsuuchi Y, Testa JR, Walsh K: Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol 1999; 19: 5073-5082.
4. Rommel C, Clarke BA, Zimmermann S, et al: Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 1999; 286: 1738-1741.
5. Chen Y, Li X, Eswarakumar VP, Seger R, Lonai P: Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PKB is required for embryoid body differentiation. Oncogene 2000; 19: 3750-3756.
6. Accili D, Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 2004; 117: 421-426.
7. Brunet A, Bonni A, Zigmond MJ, et al: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96: 857-868.
8. Birkenkamp KU, Coffer PJ: Regulation of cell survival and proliferation by the FOXO (Forkhead box, class O) subfamily of Forkhead transcription factors. Biochem Soc Trans 2003; 31: 292-297.
9. Bakker WJ, Blazquez-Domingo M, Kolbus A, et al: FoxO3a regulates erythroid differentiation and induces BTG1, an activator of protein arginine methyl transferase 1. J Cell Biol 2004; 164: 175-184.
10. Engstruöm M, Karlsson R, Jönsson JI: Inactivation of the forkhead transcription factor FoxO3 is essential for PKB-mediated survival of hematopoietic progenitor cells by kit ligand. Exp Hematol 2003; 31: 316-323.
11. Kashii Y, Uchida M, Kirito K, et al: A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 2000; 96: 941-949.
12. Furuyama T, Kitayama K, Shimoda Y, et al: Abnormal angiogenesis in Foxo1 (Fkhr)-deficient mice. J Biol Chem 2004; 279: 34741-34749.
13. Hosaka T, Biggs WH 3rd, Tien D, et al: Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification. Proc Natl Acad Sci U S A 2004; 101: 2975-2980.
14. Kalka C, Masuda H, Takahashi T, et al: Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 2000; 97: 3422-3427.
15. Nagata D, Mogi M, Walsh K: AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress. J Biol Chem 2003; 278: 31000-31006.
16. Skurk C, Maatz H, Kim HS, et al: The Akt-regulated forkhead transcription factor FOXO3a controls endothelial cell viability through modulation of the caspase-8 inhibitor FLIP. J Biol Chem 2004; 279: 1513-1525.
17. Urbich C, Knau A, Fichtlscherer S, et al: FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J 2005; 19: 974-976.
18. Kim SJ, Cheon SH, Yoo SJ, et al: Contribution of the PI3K/Akt/PKB signal pathway to maintenance of self-renewal in human embryonic stem cells. FEBS Lett 2005; 579: 534-540.
19. Reya T, Duncan AW, Ailles L, et al: A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 2003; 423: 409-414.
20. Paling NR, Wheadon H, Bone HK, Welham MJ: Regulation of embryonic stem cell self-renewal by phosphoinositide 3-kinase-dependent signaling. J Biol Chem 2004; 279: 48063-48070.
21. Potente M, Urbich C, Sasaki K, et al: Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization. J Clin Invest 2005; 115: 2382-2392.
22. Garry DJ, Meeson A, Elterman J, et al: Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc Natl Acad Sci U S A 2000; 97: 5416-5421.
23. Winnier GE, Hargett L, Hogan BL: The winged helix transcription factor MFH1 is required for proliferation and patterning of paraxial mesoderm in the mouse embryo. Genes Dev 1997; 11: 926-940.
24. Xuan S, Baptista CA, Balas G, Tao W, Soares VC, Lai E: Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. Neuron 1995; 14: 1141-1152.
25. Freyaldenhoven BS, Freyaldenhoven MP, Iacovoni JS, Vogt PK: Aberrant cell growth induced by avian winged helix proteins. Cancer Res 1997; 57: 123-129.
26. Rumpold H, Wolf D, Koeck R, Gunsilius E: Endothelial progenitor cells: a source for therapeutic vasculogenesis? J Cell Mol Med 2004; 8: 509-518.
27. Grant MB, May WS, Caballero S, et al: Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat Med 2002; 8: 607-612.
28. Hill JM, Zalos, G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.